NO FEE UNLESS WE WIN
FREE CASE REVIEW

“FDA to Reclassify Hydrocodone to Tighten Prescribing Protocols”

Abuse of Opioids Prompts FDA Scrutiny: The FDA has been evaluating the appropriate use of opioid products very carefully over the past several years.  Abuse and misuse of opioids has reached epidemic proportions in certain areas of the United States which prompted the FDA scrutiny. 

FDA UPDATES OPIOID LABEL TO PROMOTE SAFER USE

The Food and Drug Administration (“FDA”) has new labeling requirements for extended-release and long-acting (“ER/LA”) opioid pain relievers to ensure their safe and appropriate use. 

NOVICE TEEN DRIVERS 8 TIMES MORE LIKELY TO HAVE FATAL CRASH

A recent study conducted by the Texas A&M Transportation Institute shows that while fatal crash rates for teen drivers between 15 and 17 years old is declining, fatal crash rates for this same group of drivers when they have a passenger are increasing.

Settlement Reached in Two DePuy ASR Cases

The first DePuy ASR bellwether trial in the consolidated California state court litigation was scheduled to begin this month in San Francisco Superior Court before the Honorable Richard Kramer.